Skip to Content
Search Menu
Oncology
ONCOLOGY

Stay updated and get the latest news within oncology

News from oncology

BestPractice Nordic is covering SABCS 2023

  • / BestPractice Nordic

Aquaporin water channels in breast cancer

/ Oncology / Lene N. Nejsum / Frédéric H. Login / Trine Tramm / Henrik Hager

The Value of Real-World Data in Clinical Oncological Research

/ Oncology / Bettina Kulle Andreassen

Proton vs photon radiotherapy for brain tumors in patients with diffuse grade 2 and 3 gliomas

/ Oncology / Petter Brandal

Onkologisk Forum: Highlights in Lung Cancer Treatment

/ Oncology / Odd Terje Brustugun

Proton Therapy for Head and Neck Cancer

/ Oncology / Kenneth Jensen

ESMO 2023

ESMO 2023 Highlights: Practice-Changing Research in Gynecologic Cancers

/ Oncology / Kristina Lindemann

Two New Potential Game-Changers in the Treatment of Gastroesophageal Cancer

/ Oncology / Lene Bæksgaard

Potential New Standard of Care for Locally Advanced Cervical Cancer

/ Oncology / Kristina Lindemann

Optimizing PARP Inhibitor Therapy for Ovarian Cancer

/ Oncology / Mansoor Raza Mirza

Enabling Patient Empowerment Through Digital Monitoring

/ Oncology / Ellinor Christin Haukland

Meet the experts • ESMO 2023

Get access

Follow news from congresses

Latest articles and MEDtalks from oncology

Psychological and Behavioral Symptoms in Patients with Melanoma

/ Dermatology / Josefine Tingdal Taube Danielsen / Louise Strøm / Sofie Møgelberg Knutzen / Henrik Schmidt / Ali Amidi / Lisa M. Wu / Robert Bobby Zachariae

Trastuzumab Deruxtecan Show Maintenance of Overall Health Status and Quality of Life in Patients with HER2 Positive Metastatic Breast Cancers

/ Oncology / Giuseppe Curigliano

Maybe a Breakthrough for Patients with Untreated Locally Advanced Metastatic Urothelial Carcinoma 

/ Oncology / BestPractice Nordic

Promising Results for Enfortumab Vedotin in Neoadjuvant Treatment of Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

/ Oncology / Srikala Sridhar

Modified classification system for pulmonary adenocarcinomas

/ Oncology / Erik Thunnissen

New data for treatment of Papillary Renal Cell Carcinoma

/ Oncology / Benjamin Maughan

We participated on Onkologiapäivät 2023

Christian Von Briel

Patient reported outcomes to predict the severity of radiotherapy symptoms

/ Christian Von Briel
Onkologiapäivät23PRO-data Play the Video
Kaisa Lehtiö

Treatment areas of head and neck cancer radiation therapy

/ Kaisa Lehtiö
Onkologiapäivät23 Play the Video
Micaela Hernberg

Managing Oligometastatic Melanoma – Treatment Approaches and Perspectives

/ Micaela Hernberg
MelanomaOnkologiapäivät23 Play the Video
Ilja Kalashnikov

The Epidemiology and Genetics of Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma

/ Ilja Kalashnikov
Onkologiapäivät23DLBCL Play the Video
Hanne Kuitunen

A short update on aggressive lymphoma

/ Hanne Kuitunen
LymphomaOnkologiapäivät23 Play the Video

Precision Medicine: Bridging the Gap Between Scientific Innovation and Clinical Practice

/ BestPractice Nordic
Onkologiapäivät23
Katriina Peltola

FINPROVE: Advancing Access to Targeted Anti-Cancer Drugs for Advanced Cancers with Known Molecular Profiles

/ Katriina Peltola
Onkologiapäivät23 Play the Video

Read the latest magazine

Oncology / Hematology • No. 15 • 2023

  • Breast Cancer Focus
  • ESMO 2023
  • Half of Male Lymphoma Survivors Suffer from Erectile Dysfunction
Get access

Latest MEDtalks from oncology

Interventions designed to reduce lung cancer stigma

/ Oncology / Nathan Harrison

ESMO 2023 Highlights: Developments in Melanoma

/ Oncology / Marco Donia

Selected ESMO 2023 Highlights: Endometrial Cancer Treatment

/ Oncology / Shannon Westin

Perioperative Pembrolizumab Shows Significant OS in ResectableNon-Small-Cell Lung Cancer

/ Oncology / Jonathan Spicer

Prostate cancer: Adaptive, biomarker-driven platform trial shows that new hormonal agents have better efficacy for mCRPC

/ Oncology / Henrik Grönberg

New Treatment Possibilities for patients with recurrent or primary advanced endometrial cancer

/ Oncology / Mansoor Raza Mirza

Insights on Duo-E Trial: Advancing Endometrial Cancer Treatment with Olaparib

/ Oncology / Shannon Westin

Highlights from ASCO 2023 – New Insights into Luminal Breast Cancer

/ Bent Ejlertsen
Breast cancerASCO23

The CHASIT Study Explores New Treatment Approach for Advanced Urothelial Cancer

/ Vera Rutten / Tahlita Zuiverloon / Joost L. Boormans
Bladder cancer

CheckMate 227: 6-year data on the treatment of locally advanced NSCLC with Opdivo and Yervoy  

/ BestPractice Nordic
NSCLCWCLC23Lung cancer

Adjuvant treatment with 3rd generation EGFR-TKI can increase progression-free survival 

/ BestPractice Nordic
NSCLCWCLC23Lung cancer

WCLC 2023 – NSCLC: New Data on Perioperative Immunotherapy Treatment 

/ BestPractice Nordic
ImmunotherapyNSCLCWCLC23Lung cancer

Symptom control in cancer patients: Exploring the benefits of olanzapine.

/ Rony Dev / Sonal Admane
Cancer

HER2-Low treatment – The future of this important biomarker

/ Paolo Tarantino
CancerBreast cancerHER2

Trastuzumab and HER2 Targeted Cancer Treatment

/ Jan Trøst Jørgensen
HER2

Few Patients with KRAS-Mutated Tumors Receive Targeted Treatment

/ Ida Christine Jacobsen / Martin Højgaard
Cancer

Significant PFS Benefit for the Nivolumab + Relatlimab Combination for Patients with Unresectable or Metastatic Melanoma

/ BestPractice Nordic
MelanomaASCO23

Onkologiapäivät

We cover the Onkologiapäivät 2023 and will give you the latest news within oncology I 7.-8. September 2023

Go to Onkologiapäivät

Half of Male Lymphoma Survivors Suffer from Erectile Dysfunction

/ Hematology / Signe Micas Pedersen

No need for bone marrow biopsy of CNS lymphoma in PET-CT era

/ Hematology / Jelena Jelicic / Karen Juul-Jensen

Belamaf and Dexamethasone – Safe, Effective Multiple Myeloma Treatment

/ Hematology / Evangelos Terpos / Jan Andreasen

Adjuvant Osimertinib – New Standard of Care for Patients with Resected EGFR-mutated NSCLC

/ Oncology / BestPractice Nordic

Adjuvant pembrolizumab continue to demonstrate significant improvements for patients with stage IIB/IIC melanoma

/ Oncology / BestPractice Nordic
Se oversigt

Prolonged Progression-Free Survival in Patients with Advanced Ovarian Cancer

  • / BestPractice Nordic

We cover

ASCO | Congress Site

June 2.-6. 2023

Go to page

ASCO GI | Congress site

January 19.–21. 2023

Read more

ASCO GU | Congress Site

February 16.-18. 2023

Go to page

We cover

ESMO | Congress Site

Oktober 20.-24. 2023

Go to page

SABCS | Congress Site

December 5.-9. 2023

Go to page

More from oncology

Jaffer Ajani

Findings from the SPOTLIGHT Study Demonstrate the Power of the New Biomarker Claudin-18.2.

/ Jaffer Ajani
Gastrointestinal cancerESMO23 Play the Video
Peter Schmid

Pembrolizumab + Chemotherapy: a New Standard of Carefor Triple-Negative Breast Cancer

/ Peter Schmid
Breast cancerESMO23 Play the Video
Arlene Siefker-Radtke

Urothelial cancer: One step forward to understand how to combine and sequence treatments against novel targets

/ Arlene O. Siefker-Radtke
ESMO23 Play the Video
Thomas Powles

Keynote A39: Enfortumab Vedotin + Pembrolizumab agroundbreaking First Line Treatment in Untreated la/mUC

/ Thomas Powles
Bladder cancerESMO23 Play the Video
Fred Saad

Triplet therapy with darolutamide (DARO), androgen-deprivation therapy (ADT) and docetaxel (DOC) is a game changer in the treatment of metastatic hormone-sensitive prostate cancer

/ Fred Saad
Prostate cancerESMO23 Play the Video

Oesophageal Cancer: Active Surveillance vs. Neoadjuvant Chemoradiotherapy Followed by Surgery

/ Magnus Nilsson
Gastrointestinal cancerESMO23 Play the Video
BestPractice Nordic

What We Expect at ESMO 2023

/ BestPractice Nordic
ESMO23 Play the Video
Masahiro Tsuboi

Efficacy of Osimertinib in resected EGFR-Mutated stage IB-IIIA NSCLC

/ Masahiro Tsuboi
Lung cancer Play the Video
Giuseppe Curigliano

Trastuzumab deruxtecan in HER2-low metastatic breast cancer treatment

/ Giuseppe Curigliano
CancerBreast cancer Play the Video
Laurence Albiges

Triplets frontline therapy increases PFS for patients with previously untreated advanced renal-cell carcinoma

/ Laurence Albiges
Kidney cancer Play the Video

Back to top